Allogene Therapeutics Eulerpool Новини

Allogene Therapeutics Eulerpool News

Allogene Therapeutics Новини за акции

Allogene Therapeutics се наблюдава от множество журналисти и инвеститори по целия свят. Най-актуалните Allogene Therapeutics новини събираме тук.

• 5 юли ·

  SeekingAlpha
  Caribou's Allogeneic CAR-T Therapy: Analyzing HLA Matching And CB-010's Clinical Performance
• 1 юли ·

  Yahoo
  Allogene Therapeutics Activates Three Community Cancer Centers as First Sites for the Pivotal Phase 2 ALPHA3 Trial Evaluating Cemacabtagene Ansegedleucel (cema-cel) as First Line (1L) Consolidation Treatment for Patients with Large B-Cell Lymphoma (LBCL)
• 27 юни ·

  Yahoo
  With 56% institutional ownership, Allogene Therapeutics, Inc. (NASDAQ:ALLO) is a favorite amongst the big guns
• 27 юни ·

  Yahoo
  Allogene Therapeutics, Inc. (ALLO): Are Analysts Bullish About the Potential of This Small-Cap Stock?
• 20 юни ·

  Yahoo
  Allogene Therapeutics Initiates Pivotal Phase 2 Trial Investigating Cemacabtagene Ansegedleucel (cema-cel), an Allogeneic CAR T Product, as Part of First Line Treatment for Patients with Large B-Cell Lymphoma (LBCL) Likely to Relapse
• 20 юни ·

  Thefly.com
  Allogene Therapeutics initiates Phase 2 cema-cel trial
• 17 юни ·

  TipRanks
  Piper Sandler Remains a Buy on Allogene Therapeutics (ALLO)
• 13 юни ·

  Thefly.com
  Allogene Therapeutics participates in a conference call with JPMorgan
• 12 юни ·

  Yahoo
  Allogene Therapeutics (ALLO) Down 13.9% Since Last Earnings Report: Can It Rebound?
• 12 юни ·

  SeekingAlpha
  Allogene: Two End Of 2024 Data Readouts With Improved Allogeneic CAR-T Products